Epidermolysis Bullosa Simplex - Cell Biology

Relevant Publications

Ocular Gene Therapy in a Patient with Dystrophic Epidermolysis Bullosa.

Issue Release: 2024

Molecular profiling of an Indian EB cohort - a single centre experience.

Issue Release: 2024

Pathological Mechanisms Involved in Epidermolysis Bullosa Simplex: Current Knowledge and Therapeutic Perspectives.

Issue Release: 2024

Identification of novel gene variants in two Chinese patients with sporadic form of epidermolysis bullosa simplex: A case report.

Issue Release: 2024

Advanced gene-editing strategy for epidermolysis bullosa simplex.

Issue Release: 2024

Epidermolysis Bullosa: Two rare case reports of COL7A1 and EBS-GEN SEV KRT14 variants with review of literature.

Issue Release: 2024

Syndromic epidermolysis bullosa simplex subtype due to mutations in the gene: series of case reports in Russian families.

Issue Release: 2024

Descriptive Study of the Clinical and Molecular Features of Epidermolysis Bullosa Patients in a Romanian European Reference Network-Skin Affiliated Reference Center.

Issue Release: 2024

Small fiber neuropathy in epidermolysis bullosa simplex.

Issue Release: 2024

Exploring the Impact of Epidermolysis Bullosa on Parents and Caregivers: A Cross-Cultural Validation of the Epidermolysis Bullosa Burden of Disease Questionnaire.

Issue Release: 2024

EBS in Children with De Novo Pathogenic Variants Disturbing .

Issue Release: 2024

Localized epidermolysis bullosa simplex caused by a previously unreported substitution in the linker 12 domain of keratin 14.

Issue Release: 2024

Advantages of whole-exome sequencing over immunomapping in 67 Brazilian patients with epidermolysis bullosa.

Issue Release: 2024

Expanding the Clinical Phenotype of PLECTIN-Related Plectinopathies.

Issue Release: 2024

Hereditary epidermolysis bullosa: clinical-epidemiological profile of 278 patients at a tertiary hospital in São Paulo, Brazil.

Issue Release: 2024

Practical considerations relevant to treatment with the gene therapy beremagene geperpavec-svdt for dystrophic epidermolysis bullosa.

Issue Release: 2024

KRT5 in-frame deletion in a family of German Shepherd dogs with split paw pad disease resembling localized epidermolysis bullosa simplex in human patients.

Issue Release: 2024

Oral prosthetic rehabilitation in patients with Epidermolysis Bullosa Hereditaria: a systematic review.

Issue Release: 2023

Revolutionary breakthrough: FDA approves Vyjuvek, the first topical gene therapy for dystrophic epidermolysis bullosa.

Issue Release: 2023

Plectin deficiency in fibroblasts deranges intermediate filament and organelle morphology, migration, and adhesion.

Issue Release: 2023

How Do Hormonal Imbalances Occur in PCOS?

What is Cellular Development?

What are Tumor Suppressors?

What Are Organelles?

What Are Inhibitors?

How Do Intrinsic Factors Influence Cellular Differentiation?

What are Microglia?

What are the key cellular players in inflammation?

What Role Do Stem Cells Play in Therapeutic Interventions?

Are There Other Roles of PARP in Cells?

Partnered Content Networks

Relevant Topics